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MATERIALS AND METHODS
Recombinant human interleukin-3 (IL-3) with a specific activity of 1 X IO7 U/mg was provided by Dr J. Seehra (Genetics Institute, Cambridge, MA). Granulocytdmacrophage colony-stimulating factor (GM-CSF) and medium conditioned by Chinese hamster ovary cells transfected with an expression plasmid containing murine soluble steel factor (SF) cDNA were provided by Dr S. Clark and Dr D. Donaldson (Genetics Institute), respectively.
Recombinant human erythropoietin (Ep) was provided by Dr F.-K. Lin (AmGen, Thousand Oaks, CA). Human IL-3 used in the growth of colonies for karyotype analyses was purchased from Genzyme Diagnostics (Cambridge, MA); human GM-CSF used for this purpose was purchased from R&D Systems (Minneapolis, MN).
Bone marrow samples were aspirated from the posterior iliac crest of healthy adult volunteers according to guidelines established by the Institutional Review Board for Human Research, Medical University of South Carolina, and the Ralph H. Johnson Department of Veterans Affairs Medical Center. Mononuclear cells (MNCs) were isolated by two-cycle density-gradient centrifugation using Ficoll Paque (Pharmacia Inc, Piscataway, NJ), and nonadherent cells (NAMNCs) were obtained after adherence to plastic tissue-culture flasks. NAMNCs were enriched for CD34+ cells using fluorescein isothiocyanate (FITC)-conjugated anti-CD34 antibody. Enrichment was achieved by setting the FACStar plus cell sorter (Becton Dickinson, San Jose, CA) to recognize only FITCpositive cells and then sorting at a high rate of speed. The resulting cell population contained 15% to 20% CD34+ cells. The enriched CD34' cells were stained with phycoerythrin (PE)-conjugated antic-Kit (Amac Inc, Westbrook, ME) and fractionated into Kit-, Kit'"'", and Kithigh subpopulations. Data acquisition and analyses were performed using Lysis I1 software (Becton Dickinson).
Aliquots of the human cells were cultured in 35-mm Falcon suspension culture dishes (Becton Dickinson Labware, Lincoln Park, NJ) using a modification" of the Dishes were incubated at 37°C in a humidified atmosphere of 5% C02/95% air (vollvol). On day 14 of culture, colonies were scored on an inverted microscope using criteria described previously." Donor cells prepared from human bone marrow were injected into preimmune fetal sheep recipients using the amniotic bubble procedure described previously."~'l~l" Sorted donor cells were pooled, resuspended in a-medium containing 20% FCS and SO UlmL each of recombinant human IL-3 and GM-CSF. and transferred to Reno, NV, by overnight mail. Brief exposure to these growth factors has been shown to enhance engrafting efficiency of donor cells.I5 Twelve hundred to 5.000 donor cells were intraperitoneally transplanted into 14 fetal sheep at the gestational ages of 58 to 63 days. In eight cases, pregnancy was allowed to proceed to term ( -145 days). Two fetuses were absorbed into ewes during the gestational period. Six fetuses were killed in utero I .5 months after transplantation.
Donor cell engraftment in bone marrow. liver, thymus, and peripheral blood was assessed before and after birth, and in bone marrow and blood after birth. MNCs were prepared from the hematopoietic tissues by densitygradient separation and tested for chimerism using FITC-conjugated antibody to the human panleukocyte antigen, CD45, on a FACStar plus Row cytometer. AntLCD45 monoclonal antibody had been puntied from the conditioned medium of the hybridoma. 4B2 (American Type Culture Collection, Rockville. MD) and then conjugated with FITC. Aliquots were similarly stained with mouse IgC2a-FITC (Becton Dickinson) to rule out nonspecific binding of labeled antibody to sheep cells. Cells from normal sheep were also used as a negative control. The population was enriched for CD45' cells by setting the sorter to recognize only FITC-positive cells. CD34 expression by enriched CD45 ' cells was periodically examined using biotin-conjugated anti-CD34 and streptavidin-TRI-COLOR (Caltag Laboratories, South San Francisco, CA).
Bone marrow MNCs from fetal and newborn sheep transplanted with human sorted cells were assayed for hematopoietic colony formation in culture. Liver MNCs from fetal sheep were also examined. Bone marrow MNCs were cultured in methylcellulose at concentrations of I X IO'lmL, and liver cells at 2 x IO'lmL. The culture was stimulated by a combination of human Ep, IL-3, GM-CSF, and PHA-stimulated sheep leukocyte-conditioned medium as described previously.".'"." Colonies were counted and processed for karyotyping on days 9 and 19 of incubation at 37°C in a humidified atmosphere of 5% CO,/ 9 5 8 air (vollvol). Under this culture condition the maximal number of sheep colonies develop by day 9 of incubation and sheep colonies degenerate by day 19. whereas human colonies are maintained in good condition beyond day 19. The percentage of progenitors with human karyotype was determined by the following formula'-: ([actual no. of colonies with human karyotye]l[(total no. of colonies on day 9) + (total no. of colonies on day 19)1] X 100. Karyotype analysis was performed as described previously.".'"
RESULTS

Kit expression of CD34' cells, The distinction between
Kit'"" and KithiFh cell populations is arbitrary. After a number of preliminary analyses we have chosen the gates for the two cell populations that generally result in near-equal distributions of colony-forming cells between the two populations. A forward light-scatter versus side light-scatter window and the gates for Kit protein expression of cells used in transplantation no. 1 (Table 2) Table 1 . CD34' Kit-cells produced only a few colonies. A combination of IL-3 and SF promoted significant colony formation from both Kit'"" and KithIFh populations. Although the progenitors are more concentrated in the CD34' KithtEh population than in the Kit'"" population, distribution of total progenitors is almost equal because the CD34' Kit'"" population had more cells than the KithIFh population (Fig IB) .
In utero trnnsplnntntion of him" hone marrow cells. An outline of two transplantations is presented in Table 2 . In the two experiments, we transplanted human marrow cells into a total of 14 fetuses. Of these animals, six were killed before birth and examined for the presence of human cells 1 .S months after transplantation. Two fetuses were absorbed. and six fetuses, including one injected with CD34' Kitcells, two injected with CD34" Kit'"" cells, and three injected 
CD34-FITC
with CD34' KithIFh cells, were delivered alive and evaluated for signs of engraftment. Six weeks after injections of enriched human marrow cells six fetuses were killed and their bone marrow, peripheral blood, thymus, and liver were tested for the presence of human CD45' cells. Results of the analysis are presented in Table 3 . According to plating efficiencies shown in Table I , fetuses injected with Kit'"Fh cells received twice as many progenitors as fetuses receiving Kit'"" cells. One of two fetuses each receiving Kit-or Kith'Fh cells showed low-level expression of human CD4.5' cells. Both fetuses receiving transplantation of Kit'"" cells showed a significant number of CD45' cells in bone marrow and other tissues. As we described previously," the peripheral blood of these fetuses did not show signs of engraftment with human cells. These results indicate that intermediate-term engraftment could be provided by CD34' Kit'"" cells. Long-term engrajiment by him" cells. The six fetuses that were born alive also represented the three separate groups. These sheep were serially studied for the expression of chimerism with human cells. Results of serial analyses of CD4.5' cells in the chimeric sheep are presented in Fig 3. Whereas none of four sheep transplanted with CD34' Kitcells or CD34' KithIph cells showed signs of engraftment. two sheep transplanted with CD34' Kit'"" cells clearly showed signs of long-term engraftment with human cells. In one sheep. the sample taken 6 months after transplantation did not contain CD45' cells. This is likely to be due to patchy distribution of human cells. as suggested prev i o~s l y .~~' " '~ These observations demonstrated that the human stem cells capable of long-term engraftment are predominately in the CD34' Kit'"" population. In both sheep, we observed not only CD45' cells, but also CD45' CD34' cells. In general. CD4. 5 
' CD34' cells ranged from 4% to
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LONG-TERM ENGRAFTMENT BY CD34' KIT'""' CELLS
C o n f m t i o n of the chimerism by karyotype analysis of hematopoietic colonies.
The presence of human cells in the bone marrow of transplanted fetuses was also confirmed by karyotype analysis of the hematopoietic colonies. At 1.5 months after transplantation, bone marrow cells were harvested from the fetuses and cultured in methylcellulose as described earlier. GM colonies, erythroid bursts, and Emix colonies were individually harvested on day 19 of culture and processed for karyotype analysis. Results of the analysis are presented in Table 4 . The incidence (percentage) of colonies with human karyotype was calculated relative to the number of colonies identified on day 9 of incubation as described previ0us1y.l~ However, it should be noted that all colonies analyzed on day 19 were of human origin. This is consistent with previous data that only human colonies survive in culture to day 19." A significant presence of colonies with human karyotype was seen only in fetuses transplanted with CD34+ Kit'" human cells. Results of similar studies of newborn sheep 3 to 7 months after transplantation are shown in Table 5 . Again, primarily sheep transplanted with CD34+ Kitlow cells showed karyotypic evidence of chimerism. Results shown in Table 5 are generally in agreement with the analysis of CD45' cells presented in Table 3 and Fig 3. Statistical analysis. Since the numbers of transplantations were relatively small, we used Fisher's exact test for contingency tables" to test the level of significance of our observations. The null hypothesis we tested was that there is no difference in the combined Kithigh and Kit-groups when compared with the Kit'"" group. Of the total of 12 animals presented in Table 3 and Fig 3, four Kit'" animals were positive, whereas a total of eight Kithigh and Kit-animals failed to show significant engraftment. If the null hypothesis of no difference was true, such an event would have a probability of 1 in 495 of occurring by chance (ie, P < .003).
DISCUSSION
The importance of the Kit-SF system in the hematopoiesis of fetal mice is clearly demonstrated by the lethal defects in hematopoiesis of homozygosity of W and S1 genes. The For personal use only. on September 14, 2017. by guest www.bloodjournal.org From Numbers in parentheses indicate the actual number of colonies with human karyotype. All colonies analyzed on day 19 were of human origin.
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Abbreviation: NT. not tested.
stem cells with long-term engraftment capabilities. Gene therapy with hematopoietic stem cells promises to be an important approach for a number of genetic diseases and cancers. For research in these areas to proceed, availability of an assay for human hematopoietic stem cells becomes of paramount importance. Although a number of methods, both in vitro and in vivo, have been proposed, in utero xenogeneic transplantation in sheep is considered clearly one of the better choices. It may have an advantage over other xenogeneic systems because it offers the transplanted stem cells a fetal hematopoietic environment that is physiologically programed to support expansion of hematopoietic stem cells. As summarized e1sewhere:l there has been significant characterization of the in utero transplantation model using sheep. Earlier attempts to engraft with partially purified human cells were made with large numbers of cells to be grafted. Transplantation with 2 X lo4 CD34+ HLA-DRcells showed signs of engraftment." In the current study, we 
